Preliminary PET Imaging of Microtubule-Based PET Radioligand [11C]MPC-6827 in a Nonhuman Primate Model of Alzheimer's Disease.

The microtubule (MT) instability observed in Alzheimer's disease (AD) is commonly attributed to hyperphosphorylation of the MT-associated protein, tau. In vivo PET imaging offers an opportunity to gain critical information about MT changes with the onset and development of AD and related dementia. We developed the first brain-penetrant MT PET ligand, [11C]MPC-6827, and evaluated its in vivo imaging utility in vervet monkeys. Consistent with our previous in vitro cell uptake and in vivo rodent imaging experiments, [11C]MPC-6827 uptake increased with MT destabilization. Radioactive uptake was inversely related to (cerebrospinal fluid) CSF Aβ42 levels and directly related to age in a nonhuman primate (NHP) model of AD. Additionally, in vitro autoradiography studies also corroborated PET imaging results. Here, we report the preliminary results of PET imaging with [11C]MPC-6827 in four female vervet monkeys with high or low CSF Aβ42 levels, which have been shown to correlate with the Aβ plaque burden, similar to humans.

[1]  C. Whitlow,et al.  Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model , 2022, EJNMMI Research.

[2]  M. Nader,et al.  Initial Evaluations of the Microtubule-Based PET Radiotracer, [11C]MPC-6827 in a Rodent Model of Cocaine Abuse , 2022, Frontiers in Medicine.

[3]  C. Shively,et al.  Early Alzheimer's disease‐like reductions in gray matter and cognitive function with aging in nonhuman primates , 2022, Alzheimer's & dementia.

[4]  C. Shively,et al.  Nonhuman primates at the intersection of aging biology, chronic disease, and health: An introduction to the American Journal of Primatology Special Issue on aging, cognitive decline, and neuropathology in nonhuman primates , 2021, American journal of primatology.

[5]  M. Dichgans,et al.  Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals , 2021, Alzheimer's research & therapy.

[6]  J. Morrison,et al.  A novel tau‐based rhesus monkey model of Alzheimer's pathogenesis , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[7]  C. Shively,et al.  Diet, psychosocial stress, and Alzheimer's disease–related neuroanatomy in female nonhuman primates , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[8]  M. Nader,et al.  PET Imaging of [11C]MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains , 2020, Molecules.

[9]  K. Blennow,et al.  Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: a pilot study , 2019, Neurobiology of Aging.

[10]  O. Hansson,et al.  Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography. , 2019, JAMA neurology.

[11]  C. Whitlow,et al.  IN VIVO EVALUATIONS OF MICROTUBULE-BASED PET RADIOTRACER, [11C]MPC-6827 IN MURINE MODELS OF ALZHEIMER'S DISEASE , 2019, Alzheimer's & Dementia.

[12]  J. Bennett,et al.  Cocaine addicted to cytoskeletal change and a fibrosis high , 2019, Cytoskeleton.

[13]  V. Solomon,et al.  Preclinical Evaluation of 111In-Labeled PEGylated Maytansine Nimotuzumab Drug Conjugates in EGFR-Positive Cancer Models , 2019, The Journal of Nuclear Medicine.

[14]  Bryan J. Neth,et al.  A nonhuman primate model of early Alzheimer’s disease pathologic change: Implications for disease pathogenesis , 2018, Alzheimer's & Dementia.

[15]  L. A. Lowery,et al.  The Role of the Microtubule Cytoskeleton in Neurodevelopmental Disorders , 2018, Front. Cell. Neurosci..

[16]  C. Whitlow,et al.  Radiosynthesis and Evaluation of [11C]HD-800, a High Affinity Brain Penetrant PET Tracer for Imaging Microtubules. , 2018, ACS medicinal chemistry letters.

[17]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.

[18]  J. Mann,et al.  Radiosynthesis and in Vivo Evaluation of [11C]MPC-6827, the First Brain Penetrant Microtubule PET Ligand. , 2018, Journal of medicinal chemistry.

[19]  Yi Su,et al.  In Vivo Characterization of Two 18F-Labeled PDE10A PET Radioligands in Nonhuman Primate Brains. , 2018, ACS chemical neuroscience.

[20]  P. Scott,et al.  Clinical Applications of Small-molecule PET Radiotracers: Current Progress and Future Outlook. , 2017, Seminars in nuclear medicine.

[21]  J. Trojanowski,et al.  Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs , 2017, Neurobiology of Disease.

[22]  Matthew R. Bailey,et al.  The Critical Role of Nonhuman Primates in Medical Research , 2017, Pathogens & immunity.

[23]  D. Van Dam,et al.  Non human primate models for Alzheimer’s disease-related research and drug discovery , 2017, Expert opinion on drug discovery.

[24]  E. Dent.  Of microtubules and memory: implications for microtubule dynamics in dendrites and spines , 2017, Molecular biology of the cell.

[25]  J. Chuckowree,et al.  A Case for Microtubule Vulnerability in Amyotrophic Lateral Sclerosis: Altered Dynamics During Disease , 2016, Front. Cell. Neurosci..

[26]  Yi Su,et al.  Comparison of [11C]TZ1964B and [18F]MNI659 for PET imaging brain PDE10A in nonhuman primates , 2016, Pharmacology research & perspectives.

[27]  J. Trojanowski,et al.  Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimer’s Disease and Related Tauopathies , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[28]  C. Jack,et al.  Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria , 2016, Alzheimer's & Dementia.

[29]  E. Mandelkow,et al.  Tau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic Paraplegia , 2015, Molecular Neurodegeneration.

[30]  J. Perlmutter,et al.  Synthesis of Fluorine-Containing Phosphodiesterase 10A (PDE10A) Inhibitors and the In Vivo Evaluation of F-18 Labeled PDE10A PET Tracers in Rodent and Nonhuman Primate. , 2015, Journal of medicinal chemistry.

[31]  Courtney A. Miller,et al.  The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use. , 2015, CNS & neurological disorders drug targets.

[32]  Henning Urlaub,et al.  Tau stabilizes microtubules by binding at the interface between tubulin heterodimers , 2015, Proceedings of the National Academy of Sciences.

[33]  Jean-Michel Verdier,et al.  Lessons from the analysis of nonhuman primates for understanding human aging and neurodegenerative diseases , 2015, Front. Neurosci..

[34]  Napatkamon Ayutyanont,et al.  Brain glucose and acetoacetate metabolism: a comparison of young and older adults , 2014, Neurobiology of Aging.

[35]  C. Shively,et al.  Sertraline effects on cerebrospinal fluid monoamines and species-typical socioemotional behavior of female cynomolgus monkeys , 2014, Psychopharmacology.

[36]  E. Mandelkow,et al.  Amyloid‐β oligomers induce synaptic damage via Tau‐dependent microtubule severing by TTLL6 and spastin , 2013, The EMBO journal.

[37]  M. Prendergast,et al.  Ethanol impairs microtubule formation via interactions at a microtubule associated protein-sensitive site. , 2013, Alcohol.

[38]  P. Dráber,et al.  Tubulins as therapeutic targets in cancer: from bench to bedside. , 2012, Current pharmaceutical design.

[39]  J. Canales,et al.  Chronic ethanol exposure alters the levels, assembly, and cellular organization of the actin cytoskeleton and microtubules in hippocampal neurons in primary culture. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[40]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[41]  Roger Lecomte,et al.  PET study of 11C-acetoacetate kinetics in rat brain during dietary treatments affecting ketosis. , 2009, American journal of physiology. Endocrinology and metabolism.

[42]  M. Nader,et al.  Positron emission tomography imaging studies of dopamine receptors in primate models of addiction , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[43]  Robert H Mach,et al.  PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys , 2006, Nature Neuroscience.

[44]  M. Nader,et al.  PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. , 2005, The American journal of psychiatry.

[45]  F. Mastronardi,et al.  Molecules affecting myelin stability: A novel hypothesis regarding the pathogenesis of multiple sclerosis , 2005, Journal of neuroscience research.

[46]  M. Kirschner,et al.  Tau protein binds to microtubules through a flexible array of distributed weak sites , 1991, The Journal of cell biology.

[47]  A. Cadete-Leite,et al.  A quantitative study of frontal cortex dendritic microtubules in patients with Alzheimer's disease , 1987, Brain Research.

[48]  M. Kirschner,et al.  Dynamic instability of microtubule growth , 1984, Nature.

[49]  N. Freimer,et al.  Systems biology of the vervet monkey. , 2013, ILAR journal.